Abstract: Our work established a biomaterial paradigm that concurrently targets pathogen vulnerabilities and restores tissue homeostasis, addressing the multidimensional complexity of chronic wounds.
Introduction
Diabetic foot ulcers (DFUs) represent a critical challenge in regenerative medicine, characterized by a persistent cycle of high glucose, chronic inflammation, and oxidative stress. This pathological environment is highly susceptible to infections by multidrug-resistant pathogens, most notably Methicillin-resistant Staphylococcus aureus (MRSA). Traditional antibiotic treatments often fail due to poor penetration into biofilms, while conventional photothermal therapy (PTT) typically requires temperatures exceeding 60 °C, which can cause significant collateral damage to healthy tissue.
In a recent study published in the Journal of Nanobiotechnology, researchers developed a "smart" multifunctional hydrogel (COG-Z@P200) designed to eradicate MRSA at mild temperatures (40–45 °C) while simultaneously promoting tissue repair through immune reprogramming and metabolic interference.
Material Design and Characterization
The COG-Z@P200 hydrogel is a composite system featuring a double-crosslinked network of carboxymethyl chitosan (CMCS), gelatin, and oxidized sodium alginate (OSA). This framework utilizes dynamic Schiff base bonds, providing the material with essential clinical properties such as injectability and self-healing capabilities.
The therapeutic payload consists of ZIF-8 metal-organic framework nanoparticles coated with polydopamine (PDA). PDA serves as a highly efficient photothermal agent, converting near-infrared (NIR) light into mild heat. In the acidic microenvironment of a diabetic wound, the hydrogel triggers the controlled release of $Zn^{2+}$ ions, which work synergistically with the mild hyperthermia.
Synergistic Antibacterial Mechanism and Metabolic Interference
The most innovative aspect of this approach is the systematic dismantling of bacterial survival mechanisms. Multi-omics analysis (transcriptomics and metabolomics) revealed that the combination of $Zn^{2+}$ and mild heat induces a "metabolic collapse" in MRSA. Specifically, the treatment suppresses glycolysis by downregulating eno and gap genes and arrests the TCA cycle by inhibiting sucC and sdhA.
Physically, $Zn^{2+}$ ions destabilize the bacterial membrane, increasing its susceptibility to the thermal stress of mild hyperthermia. This synergy achieved a >99.5% kill rate in vitro and 98% in vivo, effectively silencing virulence factors and quorum sensing genes (e.g., agr and sdrD), which prevents biofilm formation.
In Vivo Efficacy and Tissue Regeneration
In murine models of STZ-induced diabetic wounds infected with MRSA, the COG-Z@P200 hydrogel accelerated wound closure by 48% compared to untreated controls. Beyond its bactericidal effects, the hydrogel actively reprogrammed the local immune environment. By scavenging reactive oxygen species (ROS), it facilitated a shift in macrophage polarization from the pro-inflammatory M1 phenotype to the pro-healing M2 phenotype (marked by increased $Arg-1^+$ expression).
Histological analysis further confirmed enhanced angiogenesis, evidenced by elevated VEGF and CD31 expression, and highly organized collagen deposition. These factors collectively transformed the dysregulated diabetic wound into a pro-regenerative environment.
Conclusion
The COG-Z@P200 hydrogel offers a sophisticated, antibiotic-free strategy for managing infected chronic wounds. By targeting bacterial energy metabolism at mild temperatures and coaching the host immune response toward repair, this multifunctional biomaterial addresses the root causes of DFU persistence. Future work will focus on long-term stability and the transition toward human clinical trials.
Summary updated